Yoko Takahashi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Cardiovascular Disease

Glycemic Control

Skeletal Muscle

Clinical Practice

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Hideaki Miyoshi, Munehide Matsuhisa, Daisuke Yabe, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi
Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Hideaki Kaneto, Mike Baxter, Yoko Takahashi, Yasuo Terauchi
Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL). Advances in therapy 39 (12) (2022)
Munehide Matsuhisa, Hideaki Miyoshi, Daisuke Yabe, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi
Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)